Exelixis logo
Exelixis EXEL
$ 50.13 -1.9%

Quarterly report 2026-Q1
added 05-05-2026

report update icon

Exelixis Operating Cycle 2011-2026 | EXEL

Annual Operating Cycle Exelixis

2026 2025 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
140 - 172 248 190 142 187 213 227 245 296 496 989 - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
989 140 295

Quarterly Operating Cycle Exelixis

2026-Q1 2025-Q4 2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
156 - 171 159 157 - 166 153 134 - 177 196 252 - 228 254 254 78.1 253 194 180 54.1 245 204 103 - 201 175 179 65 188 230 171 38.2 181 74.8 68.6 77.4 96.6 102 135 47.6 48 59.2 48.9 60.6 70.8 67.9 82.1 82.7 65.8 30.3 31.6 32.1 18.9 32.1 6.78 - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
254 6.78 126

Operating Cycle of other stocks in the Biotechnology industry

Issuer Operating Cycle Price % 24h Market Cap Country
FSD Pharma FSD Pharma
HUGE
3.11 K - 5743.5 % $ 69.7 M canadaCanada
Coherus BioSciences Coherus BioSciences
CHRS
656 $ 1.57 -3.68 % $ 184 M usaUSA
Happiness Biotech Group Limited Happiness Biotech Group Limited
HAPP
1.94 K - 1.35 % $ 17.8 M chinaChina
Amphastar Pharmaceuticals Amphastar Pharmaceuticals
AMPH
237 $ 16.87 -2.49 % $ 789 M usaUSA
AgeX Therapeutics AgeX Therapeutics
AGE
186 - -10.17 % $ 12.2 K usaUSA
I-Mab I-Mab
IMAB
271 - - $ 866 M chinaChina
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
12.8 - - $ 40.3 B usaUSA
AstraZeneca PLC AstraZeneca PLC
AZN
206 - - $ 96.9 B britainBritain
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
32 - -1.52 % $ 24.7 M usaUSA
Arcturus Therapeutics Holdings Arcturus Therapeutics Holdings
ARCT
21.2 $ 7.47 -4.6 % $ 205 M israelIsrael
Eton Pharmaceuticals Eton Pharmaceuticals
ETON
189 $ 30.26 1.0 % $ 814 M usaUSA
Fortress Biotech Fortress Biotech
FBIO
325 $ 2.41 4.78 % $ 67.2 M usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
245 - -18.52 % $ 27.3 M britainBritain
AbCellera Biologics AbCellera Biologics
ABCL
173 $ 4.09 -7.05 % $ 1.22 B canadaCanada
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
129 $ 1.63 2.52 % $ 434 M britainBritain
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
104 - - - russiaRussia
Celyad Oncology SA Celyad Oncology SA
CYAD
64.4 - - $ 12.5 M belgiumBelgium
Berkeley Lights Berkeley Lights
BLI
349 - -7.31 % $ 87 M usaUSA
Generation Bio Co. Generation Bio Co.
GBIO
47.6 - - $ 344 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
61.7 - - $ 7.46 M israelIsrael
Gilead Sciences Gilead Sciences
GILD
160 $ 129.58 -1.88 % $ 161 B usaUSA
Advaxis Advaxis
ADXS
3.28 K - -9.65 % $ 45.9 M usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
115 - 5.93 % $ 314 M canadaCanada
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
126 - - $ 26.5 M usaUSA
AIkido Pharma AIkido Pharma
AIKI
17.9 - 1.93 % $ 17.4 M usaUSA
Esperion Therapeutics Esperion Therapeutics
ESPR
99.7 $ 3.12 - $ 649 M usaUSA
Aptinyx Aptinyx
APTX
46.9 - -39.0 % $ 4.57 M usaUSA
Albireo Pharma Albireo Pharma
ALBO
40.8 - -0.23 % $ 916 M usaUSA